Komori
Other Disclosures4483JMDC Inc.Information and Communications, Services and Others

Kurashiki Central Hospital and Real World Data Demonstrate the Efficiency Gains from Using Electronic Worksheets (eWS) in Clinical Trial Operations with Actual Figures from a Live Clinical Trial

In actual clinical trial operations at Kurashiki Central Hospital, electronic worksheets using RWD's TidyMed were compared with paper-based operations, confirming with actual figures that entry time and the waiting time for physician signatures, among other measures, were reduced.

Worth reading
65In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Clinical trial operations support system “TidyMed,” electronic worksheets (eWS), eSource
Applicable field (uses covered by this announcement)

Operational support for clinical trials, clinical research and post-marketing surveillance; concomitant medication entry, physician signatures and data collection

Launch dateEvaluated after going live. Specific start date: Not disclosed
What the company reported numerically
Quantitative Effects

The time required to enter one concomitant medication entry in a single cell was reduced from 2.79 minutes with paper worksheets to 0.90 minutes with eWS. For small-volume entries, the time was reduced from 5.7 minutes to 1.0 minute. Processing capacity per hour increased from approximately 6 cases to approximately 8. The amount of recorded information per case increased from 6 items to 11. The median waiting time for physician signatures was reduced from 1.8 days to 0.7 days. The proportion of signatures completed within 24 hours increased from 47% to 63%.

Usage history

Track record of implementing and operating TidyMed in actual clinical trial operations. Number of cases and implementing facilities: Not disclosed

Relationship between the counterparty and the company
JMDC Inc.4483
Relationship with the Company

Real World Data Co., Ltd. introduced TidyMed at Kurashiki Central Hospital and evaluated it using eWS and eSource in the hospital's actual clinical trials. RWD is a subsidiary of JMDC Inc.

CounterpartyOhara Memorial Kurashiki Central Medical Organization, Kurashiki Central Hospital

Located in Kurashiki, Okayama Prefecture. The hospital director is Terai Akito (寺井 章人). Founded in 1923, it is a core medical institution providing advanced acute care and highly advanced medical services.

Location (as indicated in this announcement)

Kurashiki, Okayama Prefecture (Kurashiki Central Hospital)

Impact on Business Performance

Impact on revenue and profit: Not disclosed

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredClinical trial operations support system “TidyMed,” electronic worksheets (eWS), eSource
CounterpartyOhara Memorial Kurashiki Central Medical Organization, Kurashiki Central Hospital
Counterparty overviewLocated in Kurashiki, Okayama Prefecture. The hospital director is Terai Akito (寺井 章人). Founded in 1923, it is a core medical institution providing advanced acute care and highly advanced medical services.
Relationship with the CompanyReal World Data Co., Ltd. introduced TidyMed at Kurashiki Central Hospital and evaluated it using eWS and eSource in the hospital's actual clinical trials. RWD is a subsidiary of JMDC Inc.
Launch dateEvaluated after going live. Specific start date: Not disclosed
Applicable areaOperational support for clinical trials, clinical research and post-marketing surveillance; concomitant medication entry, physician signatures and data collection
LocationKurashiki, Okayama Prefecture (Kurashiki Central Hospital)
Quantitative EffectsThe time required to enter one concomitant medication entry in a single cell was reduced from 2.79 minutes with paper worksheets to 0.90 minutes with eWS. For small-volume entries, the time was reduced from 5.7 minutes to 1.0 minute. Processing capacity per hour increased from approximately 6 cases to approximately 8. The amount of recorded information per case increased from 6 items to 11. The median waiting time for physician signatures was reduced from 1.8 days to 0.7 days. The proportion of signatures completed within 24 hours increased from 47% to 63%.
Usage historyTrack record of implementing and operating TidyMed in actual clinical trial operations. Number of cases and implementing facilities: Not disclosed
Impact on Business PerformanceImpact on revenue and profit: Not disclosed
Items this document does not state (8)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Clinical trial operations were streamlined and bottlenecks eliminated through bulk importing of prescription and injection information via integration with electronic medical records, electronic signatures, and reduced physical movement and storage of documents.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Kurashiki Central Hospital and Real World Data Demonstrate the Efficiency Gains from Using Electronic Worksheets (eWS) in Clinical Trial Operations with Actual Figures from a Live Clinical Trial | JMDC Inc. (4483) timely disclosure | Komori